Nivolumab Plus Relatlimab: First Approval
Julia Paik
Topics & Concepts
NivolumabMedicineMetastatic melanomaImmunotherapyOncologyMelanomaInternal medicineMonoclonal antibodyCombination therapyAntibodyPharmacologyCancerImmunologyCancer researchCancer Immunotherapy and BiomarkersCAR-T cell therapy researchImmunotherapy and Immune Responses